ES2096646T3 - Liposomas y geles por interdigitalizacion-fusion. - Google Patents

Liposomas y geles por interdigitalizacion-fusion.

Info

Publication number
ES2096646T3
ES2096646T3 ES91903087T ES91903087T ES2096646T3 ES 2096646 T3 ES2096646 T3 ES 2096646T3 ES 91903087 T ES91903087 T ES 91903087T ES 91903087 T ES91903087 T ES 91903087T ES 2096646 T3 ES2096646 T3 ES 2096646T3
Authority
ES
Spain
Prior art keywords
liposomes
gels
present
fusion
temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91903087T
Other languages
English (en)
Inventor
Lawrence T Boni
Andrew S Janoff
Sharma R Minchey
Walter R Perkins
Christine E Swenson
Patrick L Ahl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elan Pharmaceuticals LLC
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Application granted granted Critical
Publication of ES2096646T3 publication Critical patent/ES2096646T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1277Processes for preparing; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

ESTA INVENCION ESTA RELACIONADA CON LIPOSOMAS Y GELES DE INTERDIGITACION-FUSION (IF). ESTOS LIPOSOMAS Y GELES CAPTURAN SOLUTO ALTO RESPECTO A PROPORCIONES DE LIPIDOS, QUE INCLUYE AGENTE BIOACTIVO. ESTA INVENCION TAMBIEN ESTA RELACIONADA CON EL DESCUBRIMIENTO DE QUE LA FUSION DE LIPOSOMAS PARA PRODUCIR GEL Y LIPOSOMAS DE IF SEGUN LA PRESENTE INVENCION ES TAMAÑO DEPENDIENTE. LA PRESENTE INVENCION TAMBIEN ESTA RELACIONADA CON UN METODO PARA PRODUCIR LIPOSOMAS Y GELES DE IF. EN EL METODO DE LA PRESENTE INVENCION, LOS LIPOSOMAS DIMENSIONADOS FORMADOS POR SONICACION, EXTRUSION O PROCESOS ALTERNATIVOS SE FUNDEN EN PRESENCIA DE ETANOL U OTRO INDUCTOR ADECUADO. ESTE PROCESO TIENE COMO RESULTADO UNA COMPOSICION DE LA PRESENTE INVENCION EN FORMA DE GEL. PARA PRODUCIR LIPOSOMAS, SE EXPONEN LOS GELES A UNA TEMPERATURA NORMALMENTE, PERO NO NECESARIAMENTE, SUPERIOR A LA TEMPERATURA DE TRANSICION (TM) DEL LIPIDO UTILIZADO. LA TEMPERATURA NECESARIA POR LOS METODOS DE LA INVENCION ES AQUELLA TEMPERATURA QUEINDUCE UN CAMBIO EN LAS PROPIEDADES DEL MATERIAL DE LA MEZCLA. TAMBIEN SE PUEDE RETIRAR EL INDUCTOR. EL RESULTADO ES UNA COMPOSICION QUE COMPRENDE LIPOSOMAS QUE CONTIENEN SOLUTO ALTO RESPECTO A LAS PROPORCIONES DE LIPIDOS. LOS LIPOSOMAS Y GELES DE IF DE LA PRESENTE INVENCION SE PUEDEN UTILIZAR EN COMBINACION CON NUMEROSOS SOLUTOS, INCLUYENDO ESPECIALMENTE LOS AGENTES BIOACTIVOS
ES91903087T 1990-01-12 1991-01-11 Liposomas y geles por interdigitalizacion-fusion. Expired - Lifetime ES2096646T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46452890A 1990-01-12 1990-01-12

Publications (1)

Publication Number Publication Date
ES2096646T3 true ES2096646T3 (es) 1997-03-16

Family

ID=23844291

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91903087T Expired - Lifetime ES2096646T3 (es) 1990-01-12 1991-01-11 Liposomas y geles por interdigitalizacion-fusion.

Country Status (15)

Country Link
EP (1) EP0510086B1 (es)
JP (1) JP3131923B2 (es)
KR (1) KR920703015A (es)
AT (1) ATE146074T1 (es)
AU (1) AU652552B2 (es)
CA (1) CA2073431C (es)
DE (1) DE69123568T2 (es)
DK (1) DK0510086T3 (es)
ES (1) ES2096646T3 (es)
GR (1) GR3022701T3 (es)
HK (1) HK1007499A1 (es)
IE (1) IE910086A1 (es)
NO (1) NO305535B1 (es)
PT (1) PT96465B (es)
WO (1) WO1991010422A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5882678A (en) * 1990-01-12 1999-03-16 The Liposome Co, Inc. Interdigitation-fusion liposomes containing arachidonic acid metabolites
US5820848A (en) * 1990-01-12 1998-10-13 The Liposome Company, Inc. Methods of preparing interdigitation-fusion liposomes and gels which encapsulate a bioactive agent
US6623671B2 (en) 1990-10-05 2003-09-23 Royden M. Coe Liposome extrusion process
WO1992005772A1 (en) * 1990-10-05 1992-04-16 The Liposome Company, Inc. Liposome extrusion process
IT1255476B (it) * 1992-07-30 1995-11-02 Glicerofosfoderivati farmacologicamente attivi
MX9306373A (es) * 1992-10-14 1994-06-30 Liposome Co Inc Liposomas y geles de fusion por interdigitacion.
WO1995013797A1 (en) * 1993-11-16 1995-05-26 The Liposome Company, Inc. Interdigitation-fusion liposomes containing arachidonic acid metabolites
US5716526A (en) * 1994-01-14 1998-02-10 The Liposome Company, Inc. Method of separating materials from liposomes or lipid complexes
CN1148812A (zh) * 1994-03-28 1997-04-30 尼科梅德成像有限公司 “脂质体”
WO1996016980A1 (en) * 1994-11-29 1996-06-06 Novartis Ag Morpholinoethylamide derivatives
US6613352B2 (en) 1999-04-13 2003-09-02 Universite De Montreal Low-rigidity liposomal formulation
GR20180100082A (el) * 2018-02-28 2019-09-25 ΝΙΚΟΛΑΟΣ Α. ΦΙΚΙΩΡΗΣ ΚΑΙ ΣΙΑ ΕΤΑΙΡΕΙΑ ΠΕΡΙΟΡΙΣΜΕΝΗΣ ΕΥΘΗΝΗΣ με δ.τ. IN TOUCH HEALTH Ε.Π.Ε Μεθοδος για την παραγωγη οχηματων μεταφορας λιπιδιων
CN111387339B (zh) * 2020-02-20 2022-11-25 浙江工商大学 一种具有仿母乳脂肪球结构的大尺寸脂质体及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515736A (en) * 1983-05-12 1985-05-07 The Regents Of The University Of California Method for encapsulating materials into liposomes
JPS59218956A (ja) * 1983-05-27 1984-12-10 Fujirebio Inc 膜融合測定方法
US4544545A (en) * 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US4789633A (en) * 1984-04-19 1988-12-06 University Of Tennessee Research Corporation Fused liposome and acid induced method for liposome fusion
US4921706A (en) * 1984-11-20 1990-05-01 Massachusetts Institute Of Technology Unilamellar lipid vesicles and method for their formation
JPH0751496B2 (ja) * 1986-04-02 1995-06-05 武田薬品工業株式会社 リポソ−ムの製造法
US4962022A (en) * 1986-09-22 1990-10-09 Becton Dickinson And Company Storage and use of liposomes
US4944948A (en) * 1989-02-24 1990-07-31 Liposome Technology, Inc. EGF/Liposome gel composition and method

Also Published As

Publication number Publication date
GR3022701T3 (en) 1997-05-31
DK0510086T3 (da) 1997-06-09
WO1991010422A1 (en) 1991-07-25
CA2073431C (en) 1999-05-25
AU652552B2 (en) 1994-09-01
EP0510086A4 (en) 1993-03-17
DE69123568T2 (de) 1997-05-28
ATE146074T1 (de) 1996-12-15
EP0510086B1 (en) 1996-12-11
NO305535B1 (no) 1999-06-21
PT96465A (pt) 1991-10-15
CA2073431A1 (en) 1991-07-13
JPH05503521A (ja) 1993-06-10
KR920703015A (ko) 1992-12-17
DE69123568D1 (de) 1997-01-23
PT96465B (pt) 1998-06-30
EP0510086A1 (en) 1992-10-28
HK1007499A1 (en) 1999-04-16
AU7181791A (en) 1991-08-05
NO922735D0 (no) 1992-07-10
JP3131923B2 (ja) 2001-02-05
IE910086A1 (en) 1991-07-17
NO922735L (no) 1992-08-12

Similar Documents

Publication Publication Date Title
ES2096646T3 (es) Liposomas y geles por interdigitalizacion-fusion.
NO963241L (no) Tolags blandinger
SE7909867L (sv) Poros struktur av polytetrafluoreten och forfarande for framstellning derav
FR2317309A1 (fr) Composition presentant une affinite pour le virus de l'hepatite et procede pour l'elimination/concentration dudit virus
MX9306373A (es) Liposomas y geles de fusion por interdigitacion.
PT76420A (de) Neue quartaere 6,11-dihydro-dibenzo-<b,e>-thiepin-11-n-lakyl-norscopinether und verfahren zu deren herstellung
DE2961609D1 (en) Sila-substituted 1,4-dihydropyridine derivatives, processes for their preparation, pharmaceutical compositions and process for their preparation
DE69025908T2 (de) Leitfähige struktur bildende zusammensetzung und verfahren zur herstellung derselben
DE69130237T2 (de) Verfahren zur Herstellung von Kompositmaterial
DE3584331D1 (de) Pharmazeutische zusammensetzung und verfahren um eine antiallergische wirkung hervorzurufen.
DE69017326T2 (de) Poröses Material aus Polytetrafluorethylen und Verfahren zur Herstellung.
DE59305423D1 (de) Verfahren zur Herstellung von Di- oder Triarylmethanfarbstoffen
DE69025974T2 (de) Verfahren zur thermischen Herstellung von Bildern aus metastabilen Metallkolloiden
ATA251486A (de) Verfahren zur herstellung von neuen loeslichen und/oder schmelzbaren polyamidimid-polyimidblockcopolymeren
ATE152033T1 (de) Verfahren zur herstellung von im wesentlichen hohlzylinderförmigen giesslingen und im wesentlichen hohlzylinderförmiger giessling
JPS52782A (en) Process for production of magnetic fluid
ATE1316T1 (de) Neue d-homosteroide, verfahren zu deren herstellung und diese d-homosteroide enthaltende arzneimittel.
JPS5294073A (en) Leading-in frame and process for preparing it
KR910008786A (ko) 헬륨의 전기 분해와 열꽃 (열빔)
DE59304579D1 (de) Verfahren zur Herstellung von 1,3-Dialkyl-5-hydroxyoxindolen und deren Etherderivaten
JPS51112717A (en) Process for producing porous aluminium alloy composites
AT366986B (de) Verfahren und einrichtung zur herstellung technisch reiner magnesiumverbindungen
DD136501A1 (de) Verfahren zur herstellung von 2-furanphosphonsaeuredialkyl-estern und di-2-furylphosphinsaeurealkylestern sowie deren derivaten
JPS5565522A (en) Stretching of thermoplastic resin
AT344701B (de) Verfahren zur herstellung von neuen 2-hydrazino-6-aza-3h-1,4-benzodiazepinen, deren tautomeren und optisch-isomeren formen und salzen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 510086

Country of ref document: ES